Gaush Meditech Ltd.
HHKEX:24073.88
HKD
-0.30
(-7.18%)
ISIN
KYG3902N1051
CUSIP
G3902N105
Return %
Stock
S&P 500
1Y
-55.96
14.20
3Y
-90.18
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Xin Wei Liu
- Full Time Employees
- 893
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Building A, Zhonghui Plaza Beijing BE China
- IPO Date
- Dec 12, 2022
- Website
- gaush.com
- Similar Companies
- Business
- Gaush Meditech Ltd is a medical technology company specializing in the manufacturing and distribution of high-precision surgical instruments, orthopedic implants, and advanced medical devices. Its product portfolio includes surgical tools such as forceps, scissors, clamps; orthopedic implants like joint replacements and fixation devices; and diagnostic equipment including imaging and monitoring systems. The company serves hospitals, clinics, and healthcare providers across Asia-Pacific and other international markets. Founded in 1995, Gaush Meditech is headquartered in Hong Kong. Recent company developments include strategic partnerships with regional healthcare providers to expand its surgical instrument distribution network, and acquisitions of smaller medical device firms to enhance its product offerings in diagnostic and monitoring technologies. In the past two years, Gaush Meditech launched a new line of smart orthopedic implants with embedded sensor technology for real-time patient monitoring. These initiatives align with the company’s goal to integrate cutting-edge digital solutions into traditional medical devices, reflecting a major strategic shift towards smart healthcare technology. Gaush Meditech operates primarily in the medical device and healthcare technology industry, targeting hospitals, surgical centers, and specialty clinics. It holds a strong regional presence in Greater China, Southeast Asia, and is expanding market reach in Europe. The company maintains a mix of wholly owned subsidiaries and joint ventures to support localized manufacturing and distribution capabilities. Gaush Meditech’s comprehensive product and service offerings, coupled with recent innovations and strategic expansions, position it as a leading player in the medical technology sector with headquarters in Hong Kong since its founding in 1995.